Notice of National Cancer Institute (NCI) Participation in PA-13-355 "Advancing the Science of Geriatric Palliative Care (R21)"

Notice Number: NOT-CA-14-017

Key Dates
Release Date: January 2, 2014

Related Announcements
PA-13-355

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating in PA-13-355, entitled "Advancing the Science of Geriatric Palliative Care (R21)."

Part 1. Overview Information, the Components of Participating Organizations section has been revised as shown below to include the NCI:

Components of Participating Organizations
National Institute on Aging (NIA)
National Institute of Nursing Research (NINR)
National Cancer Institute (NCI)

Part 1. Overview Information, the Catalog of Federal Domestic Assistance (CFDA) Number(s) has been revised as shown below to include the appropriate number for the NCI, which is 93.393:

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.866, 93.361, 93.393

In Part 2. Full Text of Announcement, Section I. Funding Opportunity Description, the following examples regarding the specific interests of the NCI in this funding opportunity are added:

Funding Opportunity Description
NCI’s focus includes studies that identify factors that contribute to tolerance of and adherence to cancer therapies and improved enrollment and retention in clinical trials. Examples of specific research topics include, but are not limited to:

  • Analyzing and comparing biological, social, and psychological factors that place elderly patients at risk for poor outcomes (decreased survival, serious adverse events) during and following cancer treatment;
  • Examining the trajectory of physical and functional abilities during cancer treatment;
  • Developing and refining interventions that improve older patients’ tolerance of and adherence to cancer therapies; and 
  • Examining physician and patient factors that contribute to treatment decision-making, e.g., enrolling on clinical trials, dose reductions.

In Part 2. Section VII. Agency Contacts, the name and contact information for the NCI's representatives are added as follows:

Scientific/Research Contact(s)
Ann O'Mara, Ph.D., R.N., F.A.A.N.
National Cancer Institute (NCI)
Telephone: 240-276-7050
Email: omaraa@mail.nih.gov

Financial/Grants Management Contact(s)
Rosemary Ward
National Cancer Institute (NCI)
Telephone: 240-276-6320
Email: wardros@mail.nih.gov

All other aspects of PA-13-355 remain the same.

Inquiries

Please direct all inquiries to:

Ann O'Mara, Ph.D., R.N., F.A.A.N.
National Cancer Institute
Telephone: 240-276-7050
Email: omaraa@mail.nih.gov

 

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.